This page is an archive. Its content may no longer be accurate and was last updated on the original publication date. It is intended for reference and as a historical record only. For hep C questions, call Help4Hep BC at 1-888-411-7578.
Treatment of the hepatitis C virus (HCV) that is led by primary care physicians (PCPs) and nurse practitioners (NPs) has equal safety and efficacy as care from experienced specialists, according to a new study.
A study conducted by investigators at the University of Maryland found that composite adherence to a 12-week treatment regimen was significantly higher in primary practices, with 50% adherence with nurse practitioner practices, 41% in PCP practices, and 19% in specialty practices, according to Modern Medicine.
This shift of moving patients with HCV and HIV out of specialty care and back into primary care is being driven by the development of revolutionizing directing-acting antivirals, Dr Sarah M. Kattakuzhy, MD, told Medical Economics.
Previously, treatment for HCV was interferon-based and highly toxic. Furthermore, this form of treatment was often outside the capacity of a typical primacy care practice, Dr Kattakuzhy said.
However, patients can now be cured in as little as 3 months taking 1 pill per day. This advancement can facilitate a decentralized shift toward primary care management for most HCV patients.